Evidence map›Paper›PMID 36464783›Full record

ArticleJournal of clinical laboratory analysis2023

Evaluation of characteristic metabolites of aromatic amino acids in patients with HIV infection at different stages of disease.

Zhong-Wen Yuan, Hai-Ling Gan, Hong-Liu Jin, Xiao-Ying Feng, Ming Wang, Hua-Ping Zhou, Jing Zhang

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Metabolomics of HIV in the Modern cART Era.Advances in experimental medicine and biology · 2026
    Review
  3. Review
  4. Tryptophan catabolism via the kynurenine pathway regulates infection and inflammation: from mechanisms to biomarkers and therapies.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Zhong-Wen YuanDepartment of Pharmacy, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Hai-Ling GanSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
Hong-Liu JinDepartment of Pharmacy, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Xiao-Ying FengDepartment of Pharmacy, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Ming WangDepartment of Pharmacy, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
Hua-Ping ZhouDepartment of Pharmacy, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
Jing ZhangDepartment of Pharmacy, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0003-3443-4723
Guangzhou Eighth People's Hospital · CNThird Affiliated Hospital of Guangzhou Medical University · CNGuangzhou University of Chinese Medicine · CN

Funding

Guangzhou Medical UniversityNational Natural Science Foundation of China 81803689Natural Science Foundation of Guangdong Province 2018A030310292Project of Health Science and Technology of Guangzhou 20191A011039
6 · The paper itself

Abstract

backgroundAcquired immune deficiency syndrome (AIDS), human immunodeficiency virus (HIV) infection, and antiretroviral therapy are usually associated with metabolic disorders. Screening for biomarkers to evaluate the progression of metabolic disorders is important for the diagnosis and treatment of HIV infection. This study aimed to establish and validate a method to quantify serum aromatic amino acid (AAA) metabolites as biomarkers of metabolic disorders in patients with HIV.

methodsThe AAAs and metabolites were analyzed using high-performance liquid chromatography-tandem mass spectrometry. Pearson's correlation, heatmap, and receiver operating characteristic curve analyses were used for statistical analysis.

resultsUnder optimal detection conditions, the lower limits of phenylalanine (Phe), tryptophan (Trp), kynurenine (Kyn), tyrosine, phenylacetylglutamine (PAGln), and 5-hydroxytryptamine quantification reached 0.02, 0.02, 0.01, 0.02, 0.01, and 0.002 μg/ml, respectively, and the precision of intra- and inter-day was stay below 10.30%. Serum samples were stable for at least 6 months when stored at -80°C. The inter-group differences and associations between the biomarkers exhibited a particular volatility trend in PAGln, Trp, and Kyn metabolism in HIV-infected patients with metabolic syndrome.

conclusionsThe developed method can be used for rapid and sensitive quantification of the AAA metabolism profile in vivo to further appraise the process of HIV infection, evaluate intervening measures, conduct mechanistic investigations, and further study the utility of PAGln, a characteristic metabolite of AAA, as a biomarker of HIV infection coupled with metabolic syndrome.

Indexed as

HIV InfectionsMetabolic SyndromeAmino Acids, AromaticBiomarkersHumansTandem Mass SpectrometryTryptophanAmino Acids, AromaticBiomarkersTryptophanaromatic amino acid metaboliteshigh-performance liquid chromatography-tandem mass spectrometryhuman immunodeficiency virusmetabolic disorderphenylacetylglutamine

Identifiers

PMID36464783
PMCPMC9833958
OpenAlexW4310707966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.